Amos Nyathirombo

Amos Nyathirombo (born in 1969) is a Ugandan doctor, researcher, and lecturer specializing in ophthalmology. He is best known for his research on eye care and other tropical diseases, particularly river blindness (onchocerciasis).

Early life and education Amos Nyathirombo was born in West Nile in Zombo District. The multiyear, World Health Organization-funded research determined that moxidectin was more effective at lowering microfilariae than ivermectin, and the findings were published in The Lancet. Oral moxidectin (8 mg) was licensed by the U.S. Food and Drug Administration in 2018 for adult and children ≥12 years of age.

Public health Nyathirombo has been involved in promoting West Nile eye care. As coordinator of the Lions Club of West Nile Comprehensive Eye Care Project, he spearheaded such efforts as the donation of an ophthalmic surgical microscope (value of UGX 12 million) and a refraction set (value of UGX 2.5 million) to Nebbi General Hospital during World Sight Day outreach. These initiatives helped more than 140 individuals for eye screenings and surgeries, subsidised vision correction and hearing aid services.

Awards and recognition In 2018, Nyathirombo was honoured by Namilyango College with the NACOBA Award for Service to one's Calling- The Sciences in 2018. On 8 March 2025, on Uganda International Women's Day, President Yoweri Museveni conferred upon Nyathirombo the Diamond Jubilee Medal for his work in eye health and river blindness prevention. The event was a celebration of his years of service and contribution towards the eradication of river blindness in the area.